HIV-related neurocognitive impairment - A review

Psychology, Health and Medicine

Volumn 16, Issue 5, 2011, Pages 548-563

  Rackstraw, Simon ^a,b  

^a Mildmay Mission Hospital   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

AIDS; cognition; cognitive impairment; HIV; mental health

Indexed keywords

HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR;

AIDS DEMENTIA COMPLEX; HIV INFECTIONS; HUMANS; RISK FACTORS;

EID: 80052352560     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548506.2011.579992     Document Type: Review

References (94)

1. Ancuta, P., Kamat, A., Kunstman, K.J., Kim, E.Y., Autissier, P., Wurcel, A., ⋯ Gabuzda,, D. (2008). Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One, 3, e2516.
2. Andrade, A.S.,McGruder, H.F.,Wu, A.W., Celano, S.A., Skolasky, R.L. Jr., Selnes, O.A., ⋯ McArthur, J.C. (2005). A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clinical Infectious Diseases, 41, 875-882. (Pubitemid 41266757)
3. Antinori, A., Arendt, G., Becker, J.T., Brew, B.J., Byrd, D.A., Cherner, M., ⋯ Wojna, V.E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69, 1789-1799. (Pubitemid 350059308)
4. Argyris, E., Acheampong, E., Nunnari, G., Muhammad, M., Williams, K., & Pomerantz, R. (2003). Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. Journal of Virology, 77, 12140-12151. (Pubitemid 37339867)
5. Benedict, R.H., Mezhir, J.J., Walsh, K., & Hewitt, R.G. (2000). Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Archives of Clinical Neuropsychology, 15, 535-544. (Pubitemid 30609707)
6. Bonnet, F., Amieva, H., Bruyand, M., Dauchy, F.-A., Morlat, P., Dabis, F., ⋯ Lewden, C. (2009). High prevalence of mild neurocognitive disorders in HIV-infected patients, ANRS CO3 Aquitaine Cohort [Abstract 474]. 16th Conference on Retroviruses and Opportunistic Infections, February 8-11, Montreal, Canada.
7. British HIV Association (BHIVA). (2008). The British Association for Sexual Health and HIV (BASHH), and the British Infection Society (BIS). UK National Guidelines for HIV Testing. Retrieved from http://www.bhiva.org/ HIVTesting2008.aspx
8. Canestri, A., Lescure, F.X., Jaureguiberry, S., Moulignier, A., Amiel, C., Marcelin, A.G., ⋯ Katlama, C. (2010). Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clinical Infectious Diseases, 50, 773-778.
9. Centers for Disease Control. (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report, 36, 1S-15S.
10. Centers for Disease Control and Prevention. (2011, February). HIV Surveillance Report, 2009; vol. 21. Retrieved from http://www.cdc.gov/hiv/ topics/surveillance/resources/reports/
11. Childs, E.A., Lyles, R.H., Selnes, O.A., Chen, B., Miller, E.N., Cohen, B.A., ⋯ McArthur, J.C. (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52, 607-613. (Pubitemid 29075612)
12. Ciccarelli, N., Fabbiani, M., Di Giambenedetto, S., Fanti, I., Colafigli, M., Bracciale, L., ⋯ Silveri, M. (2010). Prevalence and correlates of minor neurocognitive disorders in asymptomatic HIV-infected outpatients [Abstract 417]. In 17th Conference on Retroviruses and Opportunistic Infections, February 16-19, San Francisco, CA.
13. Clay, C.C., Rodrigues, D.S., Ho, Y.S., Fallert, B.A., Janatpour, K., Reinhart, T.A., & Esser, U. (2007). Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. Journal of Virology, 81, 12040-12048. (Pubitemid 47623834)
14. Clifford, D.B., Mitike, M.T., Mekonnen, Y., Zhang, J., Zenebe, G., Melaku, Z., ⋯ Evans, S. (2007). Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. Journal of Neurovirology, 13, 67-72. (Pubitemid 46510146)
15. Cysique, L.A., Maruff, P., Darby, D., & Brew, B.J. (2006). The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Archives of Clinical Neuropsychology, 21, 185-194. (Pubitemid 43117194)
16. Cysique, L.A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S.P., ⋯ Ellis, R.J. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73, 342-348.
17. Davis, L.E., Hjelle, B.L., Miller, V.E., Palmer, D.L., Llewellyn, A.L., Merlin, T.L., & Wiley, C.A. (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology, 42, 1736-1739.
18. Deeks, S.G., & Phillips, A.N. (2009). HIV infection, antiretroviral treatment, ageing, and non- AIDS related morbidity. BMJ, 338, a3172.
19. Dore, G., Correll, P., Kaldor, J., & Brew, B.J. (1999). Changes to the natural history of AIDS dementia complex in the era of HAART. AIDS, 13, 1249-1253. (Pubitemid 29361096)
20. Dore, G.J., McDonald, A., Li, Y., Kaldor, J., & Brew, B.J. (2003). Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 17, 1539-1545. (Pubitemid 36900555)
21. Dulioust, A., Lerolle, N., Dolphin, P., Boufassa, F., Duracinsky, M., Delfraissy, J.-F., ⋯ Gasnault, J. (2009). High frequency of neurocognitive disorders in older HIV-infected patients despite a sustained virological and immunological response on cART: The sigma study [Abstract 459]. In 16th Conference on Retroviruses and Opportunistic Infections, February 8-11, Montreal, Canada.
22. Ellis, R., Heaton, R., Letendre, S., Badiee, J., Munoz-Moreno, J., Vaida, F., ⋯ the CHARTER Group, (2010). Higher CD4 Nadir is associated with reduced rates of HIVassociated neurocognitive disorders in the CHARTER study: Potential implications for early treatment initiation [Abstract 429]. In 17th Conference on Retroviruses and Opportunistic Infections, February 16-19, San Francisco, CA.
23. European AIDS Clinical Society (2009). Guidelines on the prevention and management of noninfectious comorbidities in HIV. Retrieved from http://www.europeanaidsclinicalsociety. org/guidelines.asp
24. Faulstich, M.E. (1987). Psychiatric aspects of AIDS. The American Journal of Psychiatry, 144, 551-556. (Pubitemid 17067325)
25. Foley, J., Ettenhofer, M., Wright, M.J., Siddiqi, I., Choi, M., Thames, A.D., ⋯ Hinkin, C.H. (2010). Neurocognitive functioning in HIV-1 infection: Effects of cerebrovascular risk factors and age. Clinical Neuropsychology, 24, 265-285.
26. Gibbie, T., Mijch, A., Ellen, S., Hoy, J., Hutchison, C., Wright, E., ⋯ Judd, F. (2006). Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year followup. HIV Medicine, 7, 112-121.
27. Goldmeier, D. (1987). Psychosocial aspects of AIDS. British Journal of Hospital Medicine, 37, 232-246.
28. González-Scarano, F., & Martín-García, J. 2005 The neuropathogenesis of AIDS. Nature Reviews Immunology 5, 69-81. (Pubitemid 40070332)
29. Gorry, P.R., Ong, C., Thorpe, J., Bannwarth, S., Thompson, K.A., Gatignol, A., ⋯ Purcell, D.F. (2003). Astrocyte infection by HIV-1: Mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Current HIV Research, 1, 463-473.
30. Gupta, J.D., Satishchandra, P., Gopukumar, K., Wilkie, F., Waldrop-Valverde, D., Ellis, R., ⋯ Kumar, M. (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. Journal of Neurovirology, 13, 195-202. (Pubitemid 47053787)
31. Health Protection Agency (2010). HIV in the United Kingdom: 2010 Report. Health Protection Report 2010, 4(47). Retrieved from http://www.hpa.org.uk/web/ HPAweb-C/1287145367237
32. Heaton, R., Franklin, D., Clifford, D., Woods, S., Mindt, M.R., Vigil, O., ⋯ Grant, I. (2009). HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: The CHARTER study [Abstract 154]. In 16th Conference on Retroviruses and Opportunistic Infections, February 8-11, Montreal, Canada.
33. Heaton, R.K., Velin, R.A., McCutchan, J.A., Gulevich, S.J., Atkinson, J.H., Wallace, M.R., ⋯ Grant, I. (1994). Neuropsychological impairment in human immunodeficiency virusinfection: Implications for employment. Psychosomatic Medicine, 56, 8-17. (Pubitemid 24054867)
34. Hilsabeck, R.C., Perry, W., & Hassanein, T.I. (2002). Neuropsychological impairment in patients with chronic hepatitis. C. Hepatology, 35, 440-446. (Pubitemid 34106387)
35. Ho, D.D., Rota, T.R., Schooley, R.T., Kaplan, J.C., Allan, J.A., Groopman, J.E., ⋯ Hirsch, M.S. (1985). Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. New England Journal of Medicine, 313, 1493-1497. (Pubitemid 16182477)
36. Holland, J.C., & Tross, S. (1985). The psychosocial and neuropsychiatric sequelae of the immunodeficiency syndrome and related disorders. Annals of International Medicine, 103, 760-764. (Pubitemid 16218401)
37. Letendre, S., FitzSimons, C., Ellis, R., Clifford, D., Collier, A., Gelman, B., ⋯ the CHARTER Group. (2010). Correlates of CSF viral loads in 1,221 volunteers of the CHARTER cohort [Abstract 172]. In 17th Conference on Retroviruses and Opportunistic Infections, February 16-19, San Francisco, CA.
38. Letendre, S., Marquie-Beck, J., Capparelli, E., Best, B., Clifford, D., Collier, A.C., ⋯ CHARTER Group. (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Archives of Neurology, 65, 65-70.
39. Levy, R.M., Bredesen, D.E., & Rosenblum, M.L. (1985). Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. Journal of Neurosurgery, 62, 475-495. (Pubitemid 15079411)
40. Liner, J., Meeker, R., & Robertson, K. (2010). CNS toxicity of antiretroviral drugs [Abstract 435]. In 17th Conference on Retroviruses and Opportunistic Infections, February 16-19, San Francisco, CA.
41. Marcotte, T.D., Wolfson, T., Rosenthal, T.J., Heaton, R.K., Gonzalez, R., Ellis, R.J., & Grant, I. (2004). HIV neurobehavioral research center group. A multimodal assessment of driving performance in HIV infection. Neurology, 63, 1417-1422. (Pubitemid 39426274)
42. Marra, C.M., Lockhart, D., Zunt, J.R., Perrin, M., Coombs, R.W., & Collier, A.C. (2003). Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology, 60, 1388-1390. (Pubitemid 36461005)
43. Marra, C.M., Zhao, Y., Clifford, D.B., Letendre, S., Evans, S., Henry, K., ⋯ Robertson, K. (2009). AIDS clinical trials group 736 study team. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS, 23, 1359-1366.
44. McArthur, J.C. (2004). HIV dementia: An evolving disease. Journal of Neuroimmunology, 157, 3-10. (Pubitemid 39576633)
45. McArthur, J.C., Haughey, N., Gartner, S., Conant, K., Pardo, C., Nath, A., & Sacktor, N. (2003). Human immunodeficiency virus-associated dementia: An evolving disease. Journal of Neurovirology, 9, 205-221. (Pubitemid 36656454)
46. McArthur, J.C., Hoover, D.R., Bacellar, H., Miller, E.N., Cohen, B.A., Becker, J.T., ⋯ Saah, A. (1993). Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS cohort study. Neurology, 43, 2245-2252. (Pubitemid 23346956)
47. Medical Foundation for AIDS & Sexual Health (2003). Recommended standards for NHS HIV services. Retrieved from http://www.medfash.org.uk/ publications/documents/Recommended- standards-for-NHS-HIV-services.pdf
48. Modi, G., Hari, K., Modi, M., & Mochan, A. (2007). The frequency and profile of neurology in Black South African HIV infected (clade C) patients - A hospital-based prospective audit. Journal of Neurological Science, 254(1-2), 60-64. (Pubitemid 46343742)
49. Moore, R.D., & Chaisson, R.E. (1999). Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS, 13, 1933-1942. (Pubitemid 29509554)
50. Munoz-Moreno, J.A., Fumaz, C.R., Ferrer, M.J., Prats, A., Negredo, E., Garolera, M., ⋯ Clotet, B. (2008). Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Research and Human Retroviruses, 24, 1301-1307.
51. Navia, B., Jordan, B.D., & Price, R.W. (1986). The AIDS dementia complex: I. Clinical features. Annals of Neurology, 19, 517-524. (Pubitemid 16085185)
52. Navia, B.A., & Price, R.W. (1987). The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Archives of Neurology, 44, 65-69. (Pubitemid 17087614)
53. Palella, F.J., Jr., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., ⋯ the HIV Outpatient Study Investigators, (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338, 853-860. (Pubitemid 28135961)
54. Paramesparan, Y., Garvey, L.J., Ashby, J., Foster, C.J., Fidler, S., & Winston, A. (2010). High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1- infected adolescents surviving to adulthood. Journal of Acquired Immune Deficiency Syndromes, 55, 134-136.
55. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., & Squier, ⋯ Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30. (Pubitemid 30432540)
56. Peluso, R., Haase, A., Stowring, L., Edwards, M., & Ventura, P. (1985). A Trojan horse mechanism for the spread of Visna virus in monocytes. Virology, 147, 231-236. (Pubitemid 16200589)
57. Portegies, P., de Gans, J., Lange, J.M., Derix, M.M., Speelman, H., Bakker, M., ⋯ Goudsmit, J. (1989). Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ, 299, 819-821. (Pubitemid 19235939)
58. Portegies, P., Enting, R.H., de Gans, J., Algra, P.R., Derix, M.M., Lange, J.M., & Goudsmit, J. (1993). Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS, 7, 669-675. (Pubitemid 23204960)
59. Power, C., Selnes, O.A., Grim, J.A., & McArthur, J.C. (1995). HIV Dementia Scale: A rapid screening test. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8, 273-278.
60. Price, R.W., & Brew, B.J. (1988). The AIDS dementia complex. Journal of Infectious Diseases, 158, 1079-1083. (Pubitemid 18266060)
61. Rippeth, J.D., Heaton, R.K., Carey, C.L., Marcotte, T.D., Moore, D.J., Gonzalez, R⋯ . Grant I.; HNRC Group (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of International Neuropsychological Society, 10, 1-14. (Pubitemid 38128457)
62. Ritola, K., Robertson, K., Fiscus, S.A., Hall, C., & Swanstrom, R. (2005). Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV- 1-associated dementia. Journal of Virology, 79, 10830-10834. (Pubitemid 41098622)
63. Ryan, E.L.,Morgello, S., Isaacs, K., Naseer,M., Gerits, P., & Manhattan, H.I.V. (2004). Brain Bank Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62, 957-962. (Pubitemid 38435785)
64. Sacktor, N., Lyles, R.H., Skolasky, R., Kleeberger, C., Selnes, O.A., Miller, E.N., ⋯ McArthur, J.C. (2001). Multicenter AIDS Cohort study. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology, 56, 257-260. (Pubitemid 32095372)
65. Sacktor, N., McDermott, M.P., Marder, K., Schifitto, G., Selnes, O.A., McArthur, J.C., ⋯ Epstein, L. (2002). HIV associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8, 136-142. (Pubitemid 34520894)
66. Sacktor, N., Nakasujja, N., Skolasky, R.L., Rezapour, M., Robertson, K., Musisi, S., ⋯ Quinn, T.C. (2009). HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clinical Infectious Diseases, 49, 780-786.
67. Sacktor, N.C., Wong, M., Nakasujja, N., Skolasky, R.L., Selnes, O.A., Musisi, S., ⋯ Katabira, E. (2005). The International HIV dementia scale: A new rapid screening test for HIV dementia. AIDS, 19, 1367-1374. (Pubitemid 41800672)
68. Schifitto, G., Peterson, D.R., Zhong, J., Ni, H., Cruttenden, K., Gaugh, M., ⋯ Gelbard, H. (2006). Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report. Neurology, 66, 919-921. (Pubitemid 43739773)
69. Schifitto, G., Zhang, J., Evans, S.R., Sacktor, N., Simpson, D., Millar, L.L., ⋯ Clifford, D.B. (2007). ACTG A5090 Team. A multicenter trial of selegiline transdermal system for HIVassociated cognitive impairment. Neurology, 69, 1314-1321. (Pubitemid 47482445)
70. Schifitto, G., Zhong, J., Gill, D., Peterson, D.R., Gaugh, M.D., Zhu, T., ⋯ Gelbard, H.A. (2009). Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment. Journal of Neurovirology, 15, 176-186.
71. Schnell, G., Price, R.W., Swanstrom, R., & Spudich, S. (2010). Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. Journal of Virology, 84, 2395-2407.
72. Simioni, S., Cavassini, M., Annoni, J.M., Rimbault Abraham, A., Bourquin, I., Schiffer, V., ⋯ Du Pasquier, R.A. (2010). Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS, 24, 1243-1250.
73. Snider, W.D., Simpson, D.M., Nielsen, S., Gold, W.M.J., Metroka, C.E., & Posner, J.B. (1983). Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Annals of Neurology, 14, 403-418. (Pubitemid 13010040)
74. Soulié , C., Tubiana, R., Simon, A., Lambert-Niclot, S., Malet, I., Canestri, A., & Marcelin, A.G. (2009). Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma. Journal of Acquired Immune Deficiency Syndrome, 51, 60-64.
75. Spector, S.A., Singh, K.K., Gupta, S., Cystique, L.A., Jin, H., Letendre, S., Heaton R.K.; HNRC Group (2010). APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS, 24, 1471-1479.
76. Stephenson, J., Woods, S., Scott, B., & Meadway, J. (2000). HIV-related brain impairment from palliative care to rehabilitation. International Journal of Palliative Nursing, 6, 6-11.
77. Thein, H.H., Maruff, P., Krahn, M.D., Kaldor, J.M., Koorey, D.J., Brew, B.J., & Dore, G.J. (2007). Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Medicine, 8, 520-528. (Pubitemid 47616831)
78. Thomas, S.A. (2004). Anti-HIV drug distribution to the central nervous system. Current Pharmaceutical Design, 10, 1313-1324. (Pubitemid 38568084)
79. Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M.F., Visco-Comandini, U., ⋯ Narciso, P. (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: Prevalence and risk factors. Journal of Acquired Immune Deficiency Syndrome, 45, 174-182. (Pubitemid 46869810)
80. Tozzi, V., Balestra, P., Galgani, S., Narciso, P., Ferri, F., Sebastiani, G., ⋯ Benedetto, A. (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1- associated neurocognitive impairment. AIDS, 13, 1889-1897. (Pubitemid 29509548)
81. Uthman, O.A., & Abdulmalik, J.O. (2008). Adjunctive therapies for AIDS dementia complex. Cochrane Database of Systeamtic Reviews, 3, CD006496.
82. Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., ⋯ Sacktor, N. (2004). Higher frequency of dementia in older HIV-1 individuals: The Hawaii aging with HIV-1 Cohort. Neurology, 63, 822-827. (Pubitemid 39297641)
83. Valcour, V.G., Shikuma, C.M., Shiramizu, B.T., Williams, A.E., Watters, M.R., Poff, P.W., ⋯ Sacktor, N.C. (2005). Diabetes, insulin resistance, and dementia among HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndrome, 38, 31-36. (Pubitemid 40094115)
84. van Sighem, A., Gras, L., Reiss, P., Brinkman, K., de Wolf, F., & ATHENA national observational cohort study. (2010). Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS, 24, 1527-1535.
85. Vassallo, M., Harvey Langton, A., Pradier, C., Ferrando, S., Cottalorda, J., Caissotti, C., ⋯ Dellamonica, P. (2009). Neuradapt: A prospective study concerning HIV-related neurocognitve impairment [Abstract 464]. In 16th Conference on Retroviruses and Opportunistic Infections, February 8-11, Montreal, Canada.
86. Winston, A., Duncombe, C., Li, P.C., Gill, J.M., Kerr, S.J., Puls, R., & Altair Study Group (2010). Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clinical Infectious Diseases, 50, 920-929.
87. Wojna, V., Skolasky, R.L., McArthur, J.C., Maldonado, E., Hechavarria, R., Mayo, R., ⋯ Nath, A. (2007). Spanish validation of the HIV dementia scale in women. AIDS Patient Care STDS, 21, 930-941.
88. Wong, M.H., Robertson, K., Nakasujja, N., Skolasky, R., Musisi, S., Katabira, E., ⋯ Sacktor, N. (2007). Frequency of and risk factors for HIV dementia in an HIV clinic in Sub-Saharan Africa. Neurology, 68, 350-355. (Pubitemid 46184210)
89. Wood, S.M., Shah, S.S., Steenhoff, A.P., & Rutstein, R.M. (2009). The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. AIDS, 23, 1859-1865.
90. Wright, E., Brew, B., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., ⋯ Wesselingh, S. (2008). Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology, 71, 50-56.
91. Wright, E.J., Grund, B., Robertson, K., Brew, B.J., Roediger, M., Bain, M.P., ⋯ Price RW; INSIGHT SMART Study Group. (2010). Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology, 75, 864-873.
92. Zhao, Y., Navia, B.A., Marra, C.M., Singer, E.J., Chang, L., Berger, J., ⋯ Schifitto, G. (2010). Adult Aids Clinical Trial Group (ACTG) 301 Team. Memantine for AIDS dementia complex: Open-label report of ACTG 301. HIV Clinical Trials, 11, 59-67.
93. Zink, M.C., Uhrlaub, J., DeWitt, J., Voelker, T., Bullock, B., Mankowski, J., ⋯ Barber, S. (2005). Neuroprotective and anti-human immunodeficiency virus activity of minocycline. Journal of the American Medical Association, 293, 2003-2011. (Pubitemid 40570894)
94. Zogg, J.B., Woods, S.P., Weber, E., Iudicello, J.E., Dawson, M.S., & Grant, I. (2010). HIV Neurobehavioral Research Center Group. HIV-associated prospective memory impairment in the laboratory predicts failures on a semi-naturalistic measure of health care compliance. Clinical Neuropsychology, 24, 945-962.